🔴 Healthcare Triangle is trading 8.6% down with no confirmed company-specific catalyst

Healthcare Triangle is trading at $0.71, down 8.60%, with no confirmed company-specific catalyst identified for the September 28 decline.

• The recent equity-purchase agreement amendment and other company news predate this session and do not establish a direct catalyst.
• Reuters reported U.S. futures fell as oil rose and inflation concerns pushed Treasury yields higher after President Trump rejected Iran’s proposal. This is market context, not confirmed company-specific causation.